Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2005, for Prestige Brands Holdings, Inc. and its indirect wholly-owned subsidiary, Prestige Brands International, LLC. The company markets, sells, and distributes over-the-counter drugs, personal care, and household cleaning brands primarily in the United States. The financial information for both registrants is identical as the holding company does not conduct ongoing operations. The company completed an initial public offering (IPO) in February 2005.
Key Financial Metrics
| Metric | Q2 2005 | Q2 2004 |
|---|---|---|
| Net Sales | $63.5 million | $67.7 million |
| Gross Profit | $35.2 million | $31.6 million |
| Gross Margin | 55.4% | 54.4% |
| Operating Income | $17.0 million | $10.7 million |
| Net Income | $4.0 million | $(5.1) million |
| EPS (Basic & Diluted) | $0.08 | $(0.33) |
| Cash from Operations | $9.8 million | $8.7 million |
| Total Debt (Long-term + Current) | $494.4 million | $495.4 million |
| Cash and Equivalents | $13.9 million | $5.3 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 6.2% to $63.5 million, driven by declines across all three segments: Over-the-Counter Drugs (-5.0%), Household Cleaning (-6.1%), and Personal Care (-11.3%).
- Profitability Improvement: Despite lower sales, Net Income turned positive ($4.0 million) compared to a loss of $5.1 million in the prior year. This was primarily due to a $3.1 million reduction in advertising and promotion expenses and the absence of a $7.6 million loss on debt extinguishment recorded in 2004.
- Interest Expense: Net interest expense decreased 23.0% to $8.5 million due to reduced indebtedness following the February 2005 IPO.
- Working Capital: Accounts receivable decreased by $11.4 million, while inventory increased by $6.4 million, reflecting a sales shortfall.
Outlook, Risks, and Contingencies
- Legal Proceedings:
- IPO Class Action: A lawsuit filed August 3, 2005, alleges violations of the Securities Act of 1933 regarding the February 2005 IPO. The company plans to defend vigorously.
- Product Liability: Two class action lawsuits allege the dextromethorphan ingredient in Little Remedies products is ineffective. The company believes these are without merit.
- Trade Dress: An appeal is pending regarding a trade dress infringement claim involving the ARTHx trademarks, though summary judgment was previously granted in the company's favor.
- Subsequent Events: On July 22, 2005, the company agreed to acquire the Chore Boy line of household cleaning products for $22.3 million. On August 4, 2005, Frank Palantoni joined as President and COO.
- Market Risks: The company faces risks related to high debt levels, dependence on a limited number of customers (one customer accounted for 22.8% of sales), and potential disruption to its single main distribution center in St. Louis.
- Guidance: The filing does not provide specific forward-looking financial guidance for the full fiscal year, noting that interim results are not necessarily indicative of annual results.
Investor Verification Checklist
- Verify the status and potential financial impact of the IPO-related class action lawsuit filed in August 2005.
- Confirm the integration progress and financial performance of the recently acquired Chore Boy brand (agreed July 2005).
- Monitor the effectiveness of cost-cutting measures, specifically the reduction in advertising spend, and whether it impacts long-term brand equity.
- Assess the company's ability to service its $494.4 million debt load given the recent sales decline.
- Review the outcome of the pending appeal in the Theodosakis trade dress litigation.